These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38239047)

  • 21. Antilipolytic drug boosts glucose metabolism in prostate cancer.
    Andersen KF; Divilov V; Koziorowski J; Pillarsetty N; Lewis JS
    Nucl Med Biol; 2013 May; 40(4):524-8. PubMed ID: 23454248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
    Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
    Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.
    Li C; Yoshimura T; Tian M; Wang Y; Kondo T; Yamamoto KI; Fujisawa M; Ohara T; Sakaguchi M; Matsukawa A
    Breast Cancer Res; 2022 Sep; 24(1):60. PubMed ID: 36096830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer Tumor pH Imaging.
    Dhakan C; Anemone A; Ventura V; Carella A; Corrado A; Pirotta E; Villano D; Romdhane F; Gammaraccio F; Aime S; Longo DL
    Metabolites; 2023 Nov; 13(11):. PubMed ID: 37999256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
    Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
    Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.
    Flores LG; Yeh HH; Soghomonyan S; Young D; Bankson J; Hu Q; Alauddin M; Huff V; Gelovani JG
    Mol Imaging Biol; 2013 Apr; 15(2):175-85. PubMed ID: 22875335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
    Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
    Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
    Rousseau C; Ruellan AL; Bernardeau K; Kraeber-Bodéré F; Gouard S; Loussouarn D; Saï-Maurel C; Faivre-Chauvet A; Wijdenes J; Barbet J; Gaschet J; Chérel M; Davodeau F
    EJNMMI Res; 2011 Sep; 1(1):20. PubMed ID: 22214534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
    Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
    Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG uptake reflects an immune-enriched subtype of thyroid cancer: Clinical implications of imaging-based molecular characterization.
    Suh HY; Choi H; Cho SW; Paeng JC; Cheon GJ; Park YJ; Kang KW
    Cancer Med; 2023 Aug; 12(16):17068-17077. PubMed ID: 37466323
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Latgé A; Boisson F; Ouadi A; Averous G; Thomas L; Imperiale A; Brasse D
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956819
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose-6-phosphatase Expression-Mediated [
    Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK
    Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models.
    Irrera P; Consolino L; Roberto M; Capozza M; Dhakan C; Carella A; Corrado A; Villano D; Anemone A; Navarro-Tableros V; Bracesco M; Dastrù W; Aime S; Longo DL
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer.
    Tezcan O; Elshafei AS; Benderski K; Rama E; Wagner M; Moeckel D; Pola R; Pechar M; Etrych T; von Stillfried S; Kiessling F; Weiskirchen R; Meurer S; Lammers T
    J Control Release; 2023 Feb; 354():784-793. PubMed ID: 36599395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
    Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
    Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation.
    Takahashi K; Nagai N; Ogura K; Tsuneyama K; Saiki I; Irimura T; Hayakawa Y
    Cancer Sci; 2015 Jul; 106(7):867-74. PubMed ID: 25940224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.